Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 49

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 49
---
 the Securities Act, 
 into an existing trading market, at prevailing market prices; or                   |

| ● | through                         
 a combination of these methods. |

We may distribute securities from time to time in one or more transactions:

| ● | at                                             
 a fixed price or prices, which may be changed; |

| ● | at                                            
 market prices prevailing at the time of sale; |

| ● | at                                                  
 prices related to such prevailing market prices; or |

| ● | at                 
 negotiated prices. |

A prospectus supplement or supplements will describe the terms of the offering of the securities, including:

| ● | the                                        
 name or names of the underwriters, if any; |

| ● | if                                                                                           
 the securities are to be offered through the selling efforts of brokers or dealers, the plan 
 of distribution and the terms of any agreement, arrangement, or understanding entered into   
 with broker(s) or dealer(s) prior to the effective date of the registration statement, and,  
 if known, the identity of any broker(s) or dealer(s) who will participate in the offering    
 and the amount to be offered through each;                                                   |

| ● | the                                                                              
 purchase price of the securities and the proceeds we will receive from the sale; |

| ● | if                                                                                            
 any of the securities being registered are to be offered otherwise than for cash, the general 
 purposes of the distribution, the basis upon which the securities are to be offered, the      
 amount of compensation and other expenses of distribution, and by whom they are to be borne;  |

| ● | any                            
 delayed delivery arrangements; |

| ● | any                                                                                         
 over-allotment options under which underwriters may purchase additional securities from us; |

| ● | any                                                                                         
 agency fees or underwriting discounts and other items constituting agents’ or underwriters’ 
 compensation;                                                                               |

| ● | any                    
 public offering price; |

| ● | any                                                                            
 discounts, commissions or commissions allowed or reallowed or paid to dealers; |

| ● | the                                                           
 identity and relationships of any finders, if applicable; and |

| ● | any                                                                  
 securities exchange or market on which the securities may be listed. |

| 20 |

Only underwriters named in the prospectus supplement will be underwriters of the securities offered by that prospectus supplement. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We may offer the securities to the public through underwriting syndicates represented